Infliximab for chronic obstructive pulmonary disease: towards a more specific inflammation targeting?
- 24 January 2006
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Investigational Drugs
- Vol. 15 (2) , 181-184
Abstract
Chronic obstructive pulmonary disease (COPD) is a predominantly smoking-related condition in which chronic progressive airways obstruction results because of inflammation that is triggered and maintained by the causative agent and enhanced during exacerbations. Inflammation is dominated by neutrophils, and macrophages and their mediators. TNF-alpha is a proinflammatory cytokine involved in COPD pathogenesis. Treatment of the stable disease is mainly inhalatory with anticholinergics, beta(2) agonsists and inhaled corticosteroids being involved in various stages of the disease. Novel therapeutic agents are currently under investigation for COPD treatment and some of them target various inflammation mediators. Infliximab is a monoclonal anti-TNF-alpha antibody with demonstrated efficacy in other autoimmune diseases, such as Crohn's disease and rheumatoid arthritis. The current study assesses the scientific rationale for the use of infliximab in COPD patients.Keywords
This publication has 9 references indexed in Scilit:
- First Study of Infliximab Treatment in Patients with Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2005
- Tumour necrosis factor α as a therapeutic target for immune-mediated inflammatory diseasesCurrent Opinion in Biotechnology, 2004
- Effects of Corticosteroids on Noninvasive Biomarkers of Inflammation in Asthma and Chronic Obstructive Pulmonary DiseaseProceedings of the American Thoracic Society, 2004
- Chronic obstructive pulmonary disease * 12: New treatments for COPDThorax, 2003
- An analysis of factors influencing short‐term and sustained response to infliximab treatment for Crohn's diseaseAlimentary Pharmacology & Therapeutics, 2003
- The cellular composition of induced sputum in chronic obstructive pulmonary diseaseEuropean Respiratory Journal, 1999
- Granulocyte Activation Markers in Induced Sputum: Comparison Between Chronic Obstructive Pulmonary Disease, Asthma, and Normal SubjectsAmerican Journal of Respiratory and Critical Care Medicine, 1997
- Elevated TNF-Alpha Production by Peripheral Blood Monocytes of Weight-Losing COPD PatientsAmerican Journal of Respiratory and Critical Care Medicine, 1996
- Differences in Interleukin-8 and Tumor Necrosis Factor-Alpha in Induced Sputum From Patients With Chronic Obstructive Pulmonary Disease or AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 1996